Chad Quinn
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Acute Myeloid Leukemia Research, Metabolomics and Mass Spectrometry Studies
Most-Cited Works
- → Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells(2013)232 cited
- → New IDH1 mutant inhibitors for treatment of acute myeloid leukemia(2015)176 cited
- → In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor(2013)110 cited
- → A Tale of Two Subunits: How the Neomorphic R132H IDH1 Mutation Enhances Production of αHG(2011)109 cited
- → Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK)(2003)109 cited
- → Azepanone-Based Inhibitors of Human and Rat Cathepsin K(2001)102 cited
- → Mutant IDH1 Enhances the Production of 2-Hydroxyglutarate Due to Its Kinetic Mechanism(2013)83 cited
- → A Photoaffinity‐Based Fragment‐Screening Platform for Efficient Identification of Protein Ligands(2020)57 cited
- → Cyclic Ketone Inhibitors of the Cysteine Protease Cathepsin K(2001)52 cited
- → How leading-edge companies are marketing, selling, and fulfilling over the Internet(1999)36 cited